Injectable remodeling hydrogels derived from alendronate-tethered alginate calcium complex for enhanced osteogenesis

Carbohydr Polym. 2023 Mar 1:303:120473. doi: 10.1016/j.carbpol.2022.120473. Epub 2022 Dec 17.

Abstract

A combination of hydrogel materials, and therapeutic agents have been actively reported to facilitate bone defect healing. However, conventionally hydrogels using cross-linker would result in low stability of the hydrogel itself, loss of agents during cross-linking, and complexity of use. In this study, alendronate was tethered to an AlA to improve its bone healing and drug-loading stability. AlA was further functionalized with Ca2+ (AlACa). A mixture of AlACa and alginate formed AlAA hydrogel. The gelation time of AlAA was sufficient for injecting into the defect site. The hydrogel stiffness was controlled, while the stress-relaxation time was fixed. In vitro cell tests demonstrated that the AlAA promoted proliferation and differentiation behaviors. In particular, AlAA showed the best mechanical stiffness with appropriate stress-relaxation and cellular behavior, indicating that it would be beneficial as a scaffold in the bone tissue engineering field.

Keywords: Alendronate; Injectable remodeling hydrogel; Mesenchymal stem cell; Osteogenesis.

MeSH terms

  • Alendronate / pharmacology
  • Alginates / pharmacology
  • Calcium
  • Hydrogels* / pharmacology
  • Osteogenesis*
  • Tissue Engineering
  • Tissue Scaffolds

Substances

  • Hydrogels
  • Alendronate
  • Calcium
  • Alginates